Golden Star Resources, Ltd (NYSE:GSS)
Golden Star Resources, Ltd (NYSE:GSS) represented a move of 0 percent or $-0.03 per share and closed its previous day trading session at $3.01. 0 Shares were traded in the last trading session with an Average Volume of 235.92 Million Shares. The stock currently has a Market Capitalization of 409.36 Million.
GOLDEN STAR RES is an un-hedged gold producer they own the Wassa gold project in Ghana and control a number of gold exploration properties in West Africa. The Company is well funded and has strong, operational focused management experienced in West Africa. The Company has become a producing gold company by consolidating a long-lived production base at Bogoso/Prestea in Ghana. Going forward, the Company will continue to focus on growing its gold business.
The stock traded between $2.43 and $4.60 over 1-Year time period showing its price to sales ratio of 1.38. Golden Star Resources, Ltd (NYSE:GSS) is currently showing an DECREASING volatility over a period of 10-Days while the 20-Days Volatility showing a INCREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $-9.32 and 200-Day Simple Moving Average of $-11.69. Its Price to Free Cash Flow is 14.78 and Price to Book of 0.
Analyst’s recommended the stock as 2.2 where 1 represents Strong Buy and 5 represents Sell.
Bovie Medical Corporation (NYSE:BVX)
In the last trading session, Bovie Medical Corporation (NYSE:BVX) added its value by 0% closing at the price of $6.79. The stock currently has market capitalization of 221.63 Million, with average volume of 182.1 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently Bovie Medical Corporation (NYSE:BVX) is showing beta of -0.3. This particular value of beta suggests that Bovie Medical Corporation (NYSE:BVX) has historically moved -30% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for Bovie Medical Corporation (NYSE:BVX) is at $-0.22.
The stock currently has RSI of 58.12. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
Bovie Medical Corporation, formerly An-Con Genetics Inc., is engaged in the manufacturing and marketing of a diverse line of medical devices and advanced coating technologies.
Bovie Medical Corporation (NYSE:BVX) topped its 52-week high price of $7.62 on 09/19/18 and 52-Week Low Price of $2.28 on 03/12/18. The Stock currently has P/E (price to earnings ttm) of 0 and Weekly volatility of 9.75% and monthly volatility of 8.43% respectively.